Glenn Heller
Impact in
- Hematology top 0.1%
- Hematopoietic Stem Cell Transplantation
- Oncology top 0.1%
- Cancer Cells and Metastasis
Papers in
-
- Prostate Cancer Treatment and Research 59
- Oncology 80
- CAR-T cell therapy research 17
- Co-authors
- Howard I. Scher (67 shared papers)Martin Fleisher (24 shared papers)Mithat Gönen (5 shared papers)Paul A. Meyers (9 shared papers)John H. Healey (7 shared papers)Andrew G. Huvos (5 shared papers)Michael P. LaQuaglia (20 shared papers)Daniel C. Danila (18 shared papers)
- Journals
- Journal of Clinical Oncology (55 papers)Blood (51 papers)Biology of Blood and Marrow Transplantation (20 papers)Clinical Cancer Research (17 papers)Cancer (15 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Glenn Heller
304 papers receiving 21.7k citations
Glenn Heller's Hit Papers
Peers
Comparison fields: 5 of 178
- Hematology 4.5k
- Oncology 6.3k
- Pulmonary and Respiratory Medicine 5.9k
- Immunology 3.9k
- Cancer Research 2.5k
Countries citing papers authored by Glenn Heller
This map shows the geographic impact of Glenn Heller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenn Heller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenn Heller more than expected).
Fields of papers citing papers by Glenn Heller
This network shows the impact of papers produced by Glenn Heller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenn Heller. The network helps show where Glenn Heller may publish in the future.
Co-authors
The 25 scholars most cited alongside Glenn Heller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 310 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. Hit paper breakdown → | 1992 | 589 |
| 2 | Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer Hit paper breakdown → | 2007 | 548 |
| 3 | Concordance probability and discriminatory power in proportional hazards regression Hit paper breakdown → | 2005 | 537 |
| 4 | Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data Hit paper breakdown → | 2009 | 507 |
| 5 | 2009 | 499 | |
| 6 | 2000 | 478 | |
| 7 | Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer Hit paper breakdown → | 2016 | 475 |
| 8 | 1999 | 404 | |
| 9 | 2005 | 377 | |
| 10 | 17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenografts. | 2002 | 373 |
| 11 | 1993 | 337 | |
| 12 | 2011 | 330 | |
| 13 | 1991 | 305 | |
| 14 | Circulating Tumor Cell Biomarker Panel As an Individual-Level Surrogate for Survival in Metastatic Castration-Resistant Prostate Cancer Hit paper breakdown → | 2015 | 303 |
| 15 | 2007 | 294 | |
| 16 | 1999 | 255 | |
| 17 | 1994 | 253 | |
| 18 | 1998 | 251 | |
| 19 | 2008 | 247 | |
| 20 | 2007 | 246 |
About Glenn Heller
Glenn Heller is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Hematology, Immunology and Molecular Biology, having authored 310 papers that have together received 22.4k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (63 papers), Prostate Cancer Treatment and Research (59 papers), Immune Cell Function and Interaction (35 papers), T-cell and B-cell Immunology (33 papers), Statistical Methods and Inference (21 papers), Neuroblastoma Research and Treatments (20 papers), Immunotherapy and Immune Responses (18 papers) and CAR-T cell therapy research (17 papers). The work is most often cited by research in Hematology (4.5k citations), Oncology (6.3k citations), Pulmonary and Respiratory Medicine (5.9k citations), Immunology (3.9k citations) and Cancer Research (2.5k citations). Glenn Heller has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Howard I. Scher, Martin Fleisher, Mithat Gönen, Paul A. Meyers, John H. Healey, Andrew G. Huvos, Michael P. LaQuaglia, Daniel C. Danila, James W. Young and Michael J. Morris. Their work appears in journals such as Journal of Clinical Oncology, Blood, Biology of Blood and Marrow Transplantation, Clinical Cancer Research and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.